Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NICO Corp.

Latest From MorphoGen Pharmaceuticals Inc.

Stem Cells--A Proliferating Ambition

Stem cells have applications in organ and tissue repair, gene therapy, drug discovery, and bioartificial organs. Companies are trying to find, grow, and control human embryonic stem cells—totipotent progenitor cells that can give rise to all the tissues in the human body. Investors are intrigued by the opportunity--after all, Sandoz bought 60% of SyStemix at a big premium--but are unnerved by the early-stage of stem cell science, and the all-or-nothing races for patents.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NICO Corp.
  • Senior Management
  • Jim Pearson, Pres. & CEO
    Jeffrey Hanthorn, VP, COO
  • Contact Info
  • NICO Corp.
    Phone: (317) 660-7118
    9190 Priority Way West Dr.
    Ste. 203
    Indianapolis, IN 46240